Shanghai Medicilon, Inc.SSE: 688202

(688202)"Shanghai Medicilon Inc."Announcement on Progress of Litigation Involving the Subsidiary

· Issued by Shanghai Medicilon, Inc. via Shanghai Stock Exchange

Filed with SSE · Stock code 688202 · · 4 pages · Chinese

Summary by 6ix AI

Shanghai Medicilon, Inc. has announced the progress of litigation involving its subsidiary, Medicilon Puyuan Pharmaceutical Technology (Shanghai) Co., Ltd. The filing details the current status of the lawsuit, including the submission of appeals by both parties and the amounts involved in the claims. It also discusses the potential impact of the litigation on the company's financial position, noting that the final outcome remains uncertain. The company emphasizes its commitment to compliance and legal integrity while actively defending its interests in the case.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

On 6ix: 6ix.com/news/688202shanghai-medicilon-incannouncement-on-progress-of-litigation-involving-the-subsidiary

Shanghai Medicilon, Inc. on 6ix

Story so far

Earlier from Shanghai Medicilon

Later from Shanghai Medicilon

All Shanghai Medicilon news releases